Please Wait.....
Report
MEA Thyroid Cancer Diagnostics Market - Industry Trends and Forecast to 2030
Market Report I 2023-01-01 I 230 Pages I Data Bridge Market Research
The Middle East and Africa thyroid cancer diagnostics market is projected to register a substantial CAGR of 4.8% from 2023 to 2030. The new market report contains data for the historic year 2021, the base year of calculation is 2022, and the forecast period is 2023 to 2030
Market Segmentation:
Middle East and Africa Thyroid cancer diagnostics Market- By Product type (Instruments, Consumables & Accessories), Test Type (Imaging Test, Blood Test, Biopsy, Others), Cancer type (Papillary Carcinoma, Follicular Carcinoma, Others), Stages (Stage I, Stage II, Stage III, Stage IV), Age Group ( 30-65, 65 and above, 21-29, Below 21), End User (Hospitals, Associated Labs, Independent Diagnostic Laboratories, Diagnostic Imaging Centers, Cancer Research Institutes, Others), Distribution Channel (Direct Tender, Retail Sales), Country (South Africa, Saudi Arabia, U.A.E., Egypt, Israel, Kuwait, Rest of Middle East and Africa) Industry Trends and Forecast to 2030
Some of the major factors contributing to the growth of the Middle East and Africa thyroid cancer diagnostics market are:
- Rising incidence and prevalence of thyroid nodules & cancer
- Rising thyroid cancer diagnostic tests rise in product approvals
- Rising awareness towards thyroid cancer
Market Players:
Some major companies which are dealing in the Middle East and Africa Thyroid cancer diagnostics market are listed below:
- FUJIFILM Holdings Corporation
- F. Hoffmann-La Roche Ltd
- Quest Diagnostics Incorporated
- Illumina
- Koninklijke Philips N.V.
- Thermo Fisher Scientific Inc.
- Siemens Healthcare GmbH
- Abbott
- General Electric Company
- QIAGEN
- DIASORIN S.P.A.
- Merck KGaA
- Hologic
- Myriad Genetics Inc.
- BIOMERIEUX
- FONAR Corp.
TABLE OF CONTENTS
1 INTRODUCTION 46
1.1 OBJECTIVES OF THE STUDY 46
1.2 MARKET DEFINITION 46
1.3 OVERVIEW OF THE MIDDLE EAST & AFRICA THYROID CANCER DIAGNOSTICS MARKET 46
1.4 LIMITATIONS 48
1.5 MARKETS COVERED 48
2 MARKET SEGMENTATION 51
2.1 MARKETS COVERED 51
2.2 GEOGRAPHICAL SCOPE 52
2.3 YEARS CONSIDERED FOR THE STUDY 53
2.4 CURRENCY AND PRICING 53
2.5 DBMR TRIPOD DATA VALIDATION MODEL 54
2.6 MULTIVARIATE MODELLING 57
2.7 PRODUCT TYPE LIFELINE CURVE 57
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 58
2.9 DBMR MARKET POSITION GRID 59
2.10 MARKET TESTING TYPE COVERAGE GRID 61
2.11 VENDOR SHARE ANALYSIS 62
2.12 SECONDARY SOURCES 63
2.13 ASSUMPTIONS 63
3 EXECUTIVE SUMMARY 64
4 PREMIUM INSIGHTS 67
4.1 PESTEL ANALYSIS 68
4.2 PORTER'S FIVE FORCES 69
4.3 GROWTH STRATEGIES ADOPTED BY KEY MARKET PLAYERS 70
5 EPIDEMIOLOGY 71
6 REGULATORY FRAMEWORK OF THE MIDDLE EAST & AFRICA THYROID CANCER DIAGNOSTICS MARKET 72
6.1 REGULATORY SCENARIO IN THE U.S. 72
6.2 REGULATORY SCENARIO IN AUSTRALIA 73
6.3 REGULATORY SCENARIO IN JAPAN 73
6.4 REGULATORY SCENARIO IN CHINA 73
7 MARKET OVERVIEW 74
7.1 DRIVERS 76
7.1.1 RISING INCIDENCE AND PREVALENCE OF THYROID NODULES AND CANCER 76
7.1.2 RISING THYROID CANCER DIAGNOSTIC TESTS 76
7.1.3 RISING PREFERENCE FOR PREVENTIVE HEALTH CHECK-UPS 77
7.1.4 RISING AWARENESS TOWARDS THYROID CANCER 77
7.2 RESTRAINTS 78
7.2.1 HIGH COST OF DIAGNOSTICS PROCEDURE 78
7.2.2 TISSUE DAMAGE DUE TO HIGH RADIATION EXPOSURE FROM IMAGING TESTS 79
7.3 OPPORTUNITIES 79
7.3.1 RISE IN HEALTHCARE EXPENDITURE FOR CANCER DIAGNOSIS AND TREATMENT 79
7.3.2 RISING OBESE POPULATION 80
7.4 CHALLENGES 80
7.4.1 STRINGENT REGULATORY FRAMEWORK FOR THE APPROVAL AND COMMERCIALIZATION OF CANCER DIAGNOSTIC PRODUCTS 80
7.4.2 LACK OF SKILLED AND CERTIFIED EXPERTISE 81
8 MIDDLE EAST & AFRICA THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE 82
8.1 OVERVIEW 83
8.2 INSTRUMENTS 86
8.2.1 PATHOLOGY BASED INSTRUMENTS 87
8.2.1.1 PCR INSTRUMENTS 87
8.2.1.2 SLIDE STAINING SYSTEMS 87
8.2.1.3 TISSUE PROCESSING SYSTEMS 87
8.2.1.4 CELL PROCESSORS 88
8.2.1.5 OTHER PATHOLOGY-BASED INSTRUMENTS 88
8.2.2 IMAGING INSTRUMENTS 88
8.2.2.1 ULTRASOUND SYSTEMS 88
8.2.2.2 CT SYSTEMS 88
8.2.2.3 MRI SYSTEMS 88
8.2.2.4 OTHERS 88
8.2.3 BIOPSY INSTRUMENTS 89
8.2.3.1 NEEDLE BIOPSY 89
8.2.3.2 ENDOSCOPIC BIOPSY 89
8.2.3.3 CORE BIOPSY 89
8.2.3.4 OTHERS 89
8.2.4 OTHERS 89
8.3 CONSUMABLES & ACCESSORIES 90
8.3.1 KITS 91
8.3.1.1 PCR KITS 91
8.3.1.2 DNA POLYMERASE KITS 91
8.3.1.3 NUCLEIC ACID ISOLATION KITS 91
8.3.1.4 OTHERS 91
8.3.2 REAGENTS 92
8.3.2.1 ASSAYS 92
8.3.2.2 BUFFERS 92
8.3.2.3 PRIMERS 92
8.3.2.4 OTHERS 92
8.3.3 PROBES 92
8.3.4 OTHER CONSUMABLES 92
9 MIDDLE EAST & AFRICA THYROID CANCER DIAGNOSTICS MARKET, BY TEST TYPE 93
9.1 OVERVIEW 94
9.2 IMAGING TEST 97
9.2.1 COMPUTED TOMOGRAPHY (CT) SCAN 98
9.2.2 MRI 98
9.2.3 POSITRON EMISSION TOMOGRAPHY (PET) SCAN 98
9.2.4 OTHERS 98
9.3 BLOOD TEST 99
9.3.1 BLOOD CHEMISTRY TESTS 100
9.3.2 COMPLETE BLOOD COUNT (CBC) 100
9.3.3 OTHERS 100
9.4 BIOPSY 100
9.4.1 NEEDLE BIOPSY 101
9.4.2 BRONCHOSCOPY BIOPSY 101
9.4.3 CORE BIOPSY 101
9.4.4 OTHERS 101
9.5 OTHERS 102
10 MIDDLE EAST & AFRICA THYROID CANCER DIAGNOSTICS MARKET, BY CANCER TYPE 103
10.1 OVERVIEW 104
10.2 PAPILLARY CARCINOMA 107
10.3 FOLLICULAR CARCINOMA 108
10.4 OTHERS 109
11 MIDDLE EAST & AFRICA THYROID CANCER DIAGNOSTICS MARKET, BY STAGES 110
11.1 OVERVIEW 111
11.2 STAGE I 114
11.3 STAGE II 115
11.4 STAGE III 116
11.5 STAGE IV 117
12 MIDDLE EAST & AFRICA THYROID CANCER DIAGNOSTICS MARKET, BY AGE GROUP 118
12.1 OVERVIEW 119
12.2 30-65 122
12.3 65 AND ABOVE 123
12.4 21-29 124
12.5 BELOW 21 125
13 MIDDLE EAST & AFRICA THYROID CANCER DIAGNOSTICS MARKET, BY END USER 126
13.1 OVERVIEW 127
13.2 HOSPITALS 130
13.3 ASSOCIATED LABS 131
13.4 INDEPENDENT DIAGNOSTIC LABORATORIES 131
13.5 DIAGNOSTIC IMAGING CENTERS 132
13.6 CANCER RESEARCH INSTITUTES 133
13.7 OTHERS 134
14 MIDDLE EAST & AFRICA THYROID CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL 135
14.1 OVERVIEW 136
14.2 DIRECT TENDER 139
14.3 RETAIL SALES 140
15 MIDDLE EAST & AFRICA THYROID CANCER DIAGNOSTICS MARKET, BY REGION 141
15.1 MIDDLE EAST AND AFRICA 142
15.1.1 SAUDI ARABIA 153
15.1.2 U.A.E. 158
15.1.3 SOUTH AFRICA 163
15.1.4 EGYPT 169
15.1.5 ISRAEL 174
15.1.6 REST OF MIDDLE EAST AND AFRICA 179
16 MIDDLE EAST & AFRICA THYROID CANCER DIAGNOSTICS MARKET: COMPANY LANDSCAPE 180
16.1 COMPANY SHARE ANALYSIS: MIDDLE EAST & AFRICA 180
17 SWOT ANALYSIS 181
18 COMPANY PROFILE 182
18.1 CANON INC. 182
18.1.1 COMPANY SNAPSHOT 182
18.1.2 COMPANY SHARE ANALYSIS 182
18.1.3 PRODUCT PORTFOLIO 183
18.1.4 RECENT DEVELOPMENTS 183
18.2 FUJIFILM CORPORATION 184
18.2.1 COMPANY SNAPSHOT 184
18.2.2 REVENUE ANALYSIS 184
18.2.3 COMPANY SHARE ANALYSIS 185
18.2.4 PRODUCT PORTFOLIO 185
18.2.5 RECENT DEVELOPMENT 185
18.3 F. HOFFMANN-LA ROCHE LTD 186
18.3.1 COMPANY SNAPSHOT 186
18.3.2 REVENUE ANALYSIS 186
18.3.3 COMPANY SHARE ANALYSIS 187
18.3.4 PRODUCT PORTFOLIO 187
18.3.5 RECENT DEVELOPMENT 187
18.4 QUEST DIAGNOSTICS INCORPORATED 188
18.4.1 COMPANY SNAPSHOT 188
18.4.2 REVENUE ANALYSIS 188
18.4.3 COMPANY SHARE ANALYSIS 189
18.4.4 PRODUCT PORTFOLIO 189
18.4.5 RECENT DEVELOPMENTS 189
18.5 ILLUMINA, INC. 191
18.5.1 COMPANY SNAPSHOT 191
18.5.2 REVENUE ANALYSIS 191
18.5.3 COMPANY SHARE ANALYSIS 192
18.5.4 PRODUCT PORTFOLIO 192
18.5.5 RECENT DEVELOPMENT 192
18.6 ABBOTT 193
18.6.1 COMPANY SNAPSHOT 193
18.6.2 REVENUE ANALYSIS 193
18.6.3 PRODUCT PORTFOLIO 194
18.6.4 RECENT DEVELOPMENT 194
18.7 BD 195
18.7.1 COMPANY SNAPSHOT 195
18.7.2 REVENUE ANALYSIS 195
18.7.3 PRODUCT PORTFOLIO 196
18.7.4 RECENT DEVELOPMENT 196
18.8 BEIJING O&D BIOTECH CO., LTD. 197
18.8.1 COMPANY SNAPSHOT 197
18.8.2 PRODUCT PORTFOLIO 197
18.8.3 RECENT DEVELOPMENTS 197
18.9 BIOMERIEUX SA 198
18.9.1 COMPANY SNAPSHOT 198
18.9.2 REVENUE ANALYSIS 198
18.9.3 PRODUCT PORTFOLIO 199
18.9.4 RECENT DEVELOPMENTS 199
18.10 DIASORIN S.P.A. 200
18.10.1 COMPANY SNAPSHOT 200
18.10.2 REVENUE ANALYSIS 200
18.10.3 PRODUCT PORTFOLIO 201
18.10.4 RECENT DEVELOPMENT 201
18.11 FONAR CORP. 202
18.11.1 COMPANY SNAPSHOT 202
18.11.2 REVENUE ANALYSIS 202
18.11.3 PRODUCT PORTFOLIO 203
18.11.4 RECENT DEVELOPMENTS 203
18.12 GENERAL ELECTRIC 204
18.12.1 COMPANY SNAPSHOT 204
18.12.2 REVENUE ANALYSIS 204
18.12.3 PRODUCT PORTFOLIO 205
18.12.4 RECENT DEVELOPMENTS 205
18.13 HOLOGIC INC. 206
18.13.1 COMPANY SNAPSHOT 206
18.13.2 REVENUE ANALYSIS 206
18.13.3 PRODUCT PORTFOLIO 207
18.13.4 RECENT DEVELOPMENT 207
18.14 KONINKLIJKE PHILIPS N.V. 208
18.14.1 COMPANY SNAPSHOT 208
18.14.2 REVENUE ANALYSIS 208
18.14.3 PRODUCT PORTFOLIO 209
18.14.4 RECENT DEVELOPMENT 209
18.15 MERCK KGAA. 210
18.15.1 COMPANY SNAPSHOT 210
18.15.2 REVENUE ANALYSIS 210
18.15.3 PRODUCT PORTFOLIO 211
18.15.4 RECENT DEVELOPMENT 211
18.16 MEDONICA CO. LTD 212
18.16.1 COMPANY SNAPSHOT 212
18.16.2 PRODUCT PORTFOLIO 212
18.16.3 RECENT DEVELOPMENT 212
18.17 MINFOUND MEDICAL SYSTEMS CO. LTD 213
18.17.1 COMPANY SNAPSHOT 213
18.17.2 PRODUCT PORTFOLIO 213
18.17.3 RECENT DEVELOPMENTS 214
18.18 MYRIAD GENETICS, INC. 215
18.18.1 COMPANY SNAPSHOT 215
18.18.2 REVENUE ANALYSIS 215
18.18.3 PRODUCT PORTFOLIO 216
18.18.4 RECENT DEVELOPMENTS 216
18.19 PLEXBIO. 217
18.19.1 COMPANY SNAPSHOT 217
18.19.2 PRODUCT PORTFOLIO 217
18.19.3 RECENT DEVELOPMENTS 217
18.20 QIAGEN 218
18.20.1 COMPANY SNAPSHOT 218
18.20.2 REVENUE ANALYSIS 218
18.20.3 PRODUCT PORTFOLIO 219
18.20.4 RECENT DEVELOPMENT 219
18.21 STERNMED GMBH 220
18.21.1 COMPANY SNAPSHOT 220
18.21.2 PRODUCT PORTFOLIO 220
18.21.3 RECENT DEVELOPMENTS 220
18.22 SIEMENS HEALTHCARE GMBH 221
18.22.1 COMPANY SNAPSHOT 221
18.22.2 REVENUE ANALYSIS 221
18.22.3 PRODUCT PORTFOLIO 222
18.22.4 RECENT DEVELOPMENT 222
18.23 TIME MEDICAL HOLDING. 223
18.23.1 COMPANY SNAPSHOT 223
18.23.2 PRODUCT PORTFOLIO 223
18.23.3 RECENT DEVELOPMENT 223
18.24 THERMO FISHER SCIENTIFIC INC. 224
18.24.1 COMPANY SNAPSHOT 224
18.24.2 REVENUE ANALYSIS 224
18.24.3 PRODUCT PORTFOLIO 225
18.24.4 RECENT DEVELOPMENT 225
19 QUESTIONNAIRE 226
20 RELATED REPORTS 230
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security